Invention Grant
- Patent Title: Deuterium-enriched pioglitazone
-
Application No.: US16531812Application Date: 2019-08-05
-
Publication No.: US10940143B2Publication Date: 2021-03-09
- Inventor: Anthony W. Czarnik
- Applicant: Poxel SA
- Applicant Address: FR Lyons
- Assignee: Poxel SA
- Current Assignee: Poxel SA
- Current Assignee Address: FR Lyons
- Agency: Goodwin Procter LLP
- Main IPC: C07D417/12
- IPC: C07D417/12 ; A61K31/4439
Abstract:
The present application describes deuterium-enriched pioglitazone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
Public/Granted literature
- US20200179360A1 DEUTERIUM-ENRICHED PIOGLITAZONE Public/Granted day:2020-06-11
Information query
